[ESPR] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -5.84%
YoY-
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 30/09/03 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,921 -4,239 -2,775 -3,351 -3,166 -2,449 -6,563 0.54%
Tax 112 803 476 362 304 261 578 -15.48%
NP -6,921 -4,239 -2,775 -3,351 -3,166 -2,449 -6,563 0.54%
Tax Rate - - - - - - - -
Total Cost 6,921 4,239 2,775 3,351 3,166 2,449 6,563 0.54%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 30/09/03 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 30/09/03 CAGR
EPS -0.47 -0.29 -0.29 -0.35 -0.33 -0.25 -1.42 -10.71%
EPS Diluted -0.47 -0.29 -0.29 -0.35 -0.33 -0.25 -1.42 -10.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.